Research ArticleArticle
CYP2C8- and CYP3A-Mediated C-Demethylation of (3-{[(4-tert-Butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic Acid (CP-533,536), an EP2 Receptor-Selective Prostaglandin E2 Agonist: Characterization of Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and Liquid Chromatography/Mass Spectrometry-Nuclear Magnetic Resonance
Chandra Prakash, Weiwei Wang, Thomas O'Connell and Kim A. Johnson
Drug Metabolism and Disposition October 2008, 36 (10) 2093-2103; DOI: https://doi.org/10.1124/dmd.108.022897
Chandra Prakash
Weiwei Wang
Thomas O'Connell
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
CYP2C8- and CYP3A-Mediated C-Demethylation of (3-{[(4-tert-Butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic Acid (CP-533,536), an EP2 Receptor-Selective Prostaglandin E2 Agonist: Characterization of Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and Liquid Chromatography/Mass Spectrometry-Nuclear Magnetic Resonance
Chandra Prakash, Weiwei Wang, Thomas O'Connell and Kim A. Johnson
Drug Metabolism and Disposition October 1, 2008, 36 (10) 2093-2103; DOI: https://doi.org/10.1124/dmd.108.022897
Research ArticleArticle
CYP2C8- and CYP3A-Mediated C-Demethylation of (3-{[(4-tert-Butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic Acid (CP-533,536), an EP2 Receptor-Selective Prostaglandin E2 Agonist: Characterization of Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and Liquid Chromatography/Mass Spectrometry-Nuclear Magnetic Resonance
Chandra Prakash, Weiwei Wang, Thomas O'Connell and Kim A. Johnson
Drug Metabolism and Disposition October 1, 2008, 36 (10) 2093-2103; DOI: https://doi.org/10.1124/dmd.108.022897
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement